Multinational fast moving consumer goods (FMCG) major Reckitt Benckiser hopes to double its revenue in India to Rs 2,500 crore over the next three years with its blockbuster anti-septic brand Dettol leading the charge.
Reckitt Benckiser India's chairman and managing director Chander Mohan Sethi told reporters that revenues from Dettol alone should reach around Rs 1,000 crore by 2010. Dettol currently contributes about Rs 400 crore the company’s total revenues, which stood at Rs 1,200 crore in 2006.
"Our future growth in Indian will be driven by increased penetration of personal and home care products and this growth is expected to drive our top-line to the Rs 2,500 crore mark by 2010," Sethi said.
"Dettol is the biggest brand retailed by Reckitt Benckiser India and we expect it to become a Rs 1,000 crore brand by 2010," he said.
The company is mulling to add several new products in its portfolio in order to achieve its turnover target by 2010 and would launch the first such product in the next three months.
"As we grow in India, our strategy would be to introduce various new products from Reckitt Benckiser's global portfolio here. The company plans to launch a new product in India within the next three months," Sethi said.
Reckitt Benckiser (India) Ltd, formerly known as Reckitt & Colman, controls popular household good brands such as Harpic, Mortein, Lizol, Cherry Blossom, Colin, Disprin and Strepsils among others.